These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1575018)

  • 1. Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease.
    Mann DM; Jones D; South PW; Snowden JS; Neary D
    Acta Neuropathol; 1992; 83(4):415-9. PubMed ID: 1575018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic findings in a case of primary progressive aphasia.
    Scheltens P; Ravid R; Kamphorst W
    Neurology; 1994 Feb; 44(2):279-82. PubMed ID: 8309574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontal lobe degeneration of non-Alzheimer type. Structural characteristics, diagnostic criteria and relation to other frontotemporal dementias.
    Brun A; Passant U
    Acta Neurol Scand Suppl; 1996; 168():28-30. PubMed ID: 8997416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method.
    Yang Y; Schmitt HP
    Acta Neuropathol; 2001 Mar; 101(3):256-70. PubMed ID: 11307626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of cardiovascular disease, apolipoprotein E genotype, and brain pathology in aging and dementia.
    Alafuzoff I; Helisalmi S; Mannermaa A; Soininen H
    Ann N Y Acad Sci; 2000 Apr; 903():244-51. PubMed ID: 10818513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
    Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
    Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal lobe dementia is not a variant of prion disease.
    Clinton J; Mann DM; Roberts GW
    Neurosci Lett; 1993 Dec; 164(1-2):1-4. PubMed ID: 8152581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
    Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW
    Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal loss in familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions.
    Cairns NJ; Brännström T; Khan MN; Rossor MN; Lantos PL
    Exp Neurol; 2003 Jun; 181(2):319-26. PubMed ID: 12782004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: comparison with non-demented cases and Alzheimer's disease.
    Armstrong RA; Cairns NJ; Lantos PL
    Dement Geriatr Cogn Disord; 2000; 11(4):187-92. PubMed ID: 10867443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Amyloid (A beta) deposition in elderly non-demented patients and patients with Alzheimer's disease.
    Armstrong RA
    Neurosci Lett; 1994 Aug; 178(1):59-62. PubMed ID: 7816341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease.
    Armstrong RA
    Dementia; 1995; 6(3):121-5. PubMed ID: 7620523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.
    Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T
    Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistent tau and amyloid pathology in hereditary frontotemporal dementia with tau mutations.
    Rosso SM; Kamphorst W; Ravid R; van Swieten JC
    Ann N Y Acad Sci; 2000; 920():115-9. PubMed ID: 11193139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Amyloid (A beta) deposition in the medial temporal lobe of patients with dementia with Lewy bodies.
    Armstrong RA; Cairns NJ; Lantos PL
    Neurosci Lett; 1997 May; 227(3):193-6. PubMed ID: 9185683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological study of amyloid fibrils and preamyloid deposits in the brain with Alzheimer's disease.
    Miyakawa T; Katsuragi S; Yamashita K; Ohuchi K
    Acta Neuropathol; 1992; 83(4):340-6. PubMed ID: 1575011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some morphometric aspects of the brain in senile dementia of the Alzheimer type.
    Terry RD; Peck A; DeTeresa R; Schechter R; Horoupian DS
    Ann Neurol; 1981 Aug; 10(2):184-92. PubMed ID: 7283403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
    Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
    Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
    Attems J; Jellinger KA
    Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia.
    Galton CJ; Gomez-Anson B; Antoun N; Scheltens P; Patterson K; Graves M; Sahakian BJ; Hodges JR
    J Neurol Neurosurg Psychiatry; 2001 Feb; 70(2):165-73. PubMed ID: 11160463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.